Literature DB >> 34332401

Rare cutaneous toxicity of immune checkpoint inhibitors: A case of durvalumab-induced dermatomyositis.

Cyrille Coustal1, Aurélie Du Thanh2, François Roubille3, Eric Assenat4, Alexandre T J Maria5.   

Abstract

Entities:  

Keywords:  Dermatomyositis; Hepatocarcinoma; Immune checkpoint inhibitors; Myasthenia gravis; Paraneoplastic syndrome

Mesh：

Substances：

Year:  2021        PMID： 34332401     DOI： 10.1016/j.ejca.2021.06.031

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

Review 1.  Cutaneous Adverse Events Associated with Immune Checkpoint Inhibitors: A Review Article.

Authors:  Chieh-Hsun Chen; Hsin-Su Yu; Sebastian Yu
Journal:  Curr Oncol       Date:  2022-04-18       Impact factor: 3.109

2.  Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by Durvalumab: A Case Report and Literature Review.

Authors:  Nathathai Pratumchart; Kumutnart Chanprapaph; Nuttapong Topibulpong; Jutamas Tankunakorn
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.